The Weekly Recap 2/21/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure over $174M in new funding, obtain regulatory approval, enter new strategic partnerships, and much more on the road to LSI USA ‘25 in Dana Point, CA (March 17-21).

Accelus

Promoted Jim Fox to Vice President of U.S. Sales, expanding his leadership role in driving nationwide commercial growth. Fox, who previously led sales in the Eastern U.S., will focus on strengthening distributor partnerships and increasing adoption of Accelus’s expandable spinal implant technologies.

Approxima

Secured €7.3M in the first closing of its Series A financing round to advance its percutaneous right ventricular reshaping technology for tricuspid valve regurgitation. The funds will support preclinical verification, first-in-human trials, and a U.S. Early Feasibility Study.

Berlin Heals

Secured over CHF 7M in funding to support first-in-human studies for less invasive implant approaches of its C-MIC device. The funds will also advance CE submission for the first-generation device and prepare for a pivotal trial to achieve global regulatory and reimbursement approvals.

Cagent Vascular

Secured $15M in growth capital funding from Trinity Capital to expand commercialization efforts. The investment will support the continued rollout of the company’s Serranator angioplasty balloon.

Ditch Labs

Appointed Peter Bloch as Chairman of the Board of Directors. Bloch brings extensive leadership experience in the medical technology sector to guide the company’s strategic direction as it prepares for a pivotal trial in the United Kingdom and clinical trials in the United States.

Egg Medical

Announced a strategic partnership with BIOTRONIK to improve radiation protection for interventional healthcare workers. The collaboration aims to enhance safety measures in EP and cath labs.

Endovascular Engineering

Raised $42M in an oversubscribed Series B funding round to advance its pulmonary embolism treatment technology. The funds will support clinical trials and regulatory efforts for its innovative thrombectomy system.

IQ Endoscopes

Secured new investment from BGF and the Development Bank of Wales to expedite the rollout of its sustainable, single-use endoscopy platform. The investment supports early commercial adoption in four UK health centers starting July 2025, aiming to improve capacity and reduce contamination risks.

Levita Magnetics

Appointed Jon Beltrone as VP of Global Sales to expand access to the company’s MARS Surgical System. With experience driving the adoption of robotic surgery systems at Stryker and Momentis, he will lead commercialization efforts to enhance minimally invasive surgery.

Lungpacer Medical

Announced positive results from the STIMULUS trial, demonstrating the benefits of diaphragm neurostimulation in mechanically ventilated patients. The findings highlight the potential for improved hemodynamic performance and patient outcomes.

MMI - Medical Microinstruments, Inc.

Received FDA 510(k) clearance for an expanded indication, allowing head and neck surgeons to use the Symani Surgical System for cancer-related reconstructive procedures. The technology enhances precision, accessibility, and ergonomics in robotic microsurgery.

Neuro Event Labs

Secured €2M in funding to expand in Europe and enter the U.S. market with its AI-powered seizure detection device, Nelli. The CE-marked, MDR-certified technology enhances epilepsy monitoring in home and hospital settings, with a U.S. launch expected this year.

Novadip Biosciences

Reported positive 12-month results from its phase 1b/2a trial of NVDX3, a stem-cell-derived bone graft for distal radius fractures. All patients achieved bone union with no adverse events, supporting plans for a phase 2b/3 cervical spine fusion trial.

Orchestra BioMed

Appointed Dr. Vivek Reddy as Executive Chairman of the BACKBEAT Study Steering Committee and Bioelectronic Therapies Scientific Advisory Board. He will support the BACKBEAT pivotal study and advance AVIM therapy for hypertension.

Retia Medical

Partnered with Medtronic to distribute the Argos Cardiac Output Monitor in the United States, expanding access for high-risk surgical and critically ill patients. The system will be featured at the Society of Critical Care Medicine annual meeting.

Solaris Endovascular

Reached a key enrollment milestone in the DEScover clinical trial, evaluating its novel drug-eluting stent technology. The study is designed to assess the safety and efficacy of the graft in patients with arteriovenous fistulae (AVF) and arteriovenous grafts (AVG).

Visura Technologies

Presented new U.S. registry data from 15 heart centers demonstrating the efficacy of the TEEcad system. The findings support the clinical utility of the device in transesophageal echocardiography procedures.

VitalConnect

Secured a $100M investment to expand its remote patient monitoring solutions. The funding will support scaling production and accelerating commercial growth of its wearable biosensor technology.

Stay tuned for more updates, insights, and achievements of our LSI Alumni in The Weekly Recap, and follow our blog for the latest medical device news and advancements.